Leap Therapeutics

$1.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 6:17 PM UTC today

Why Robinhood?

You can buy or sell LPTX and other stocks, options, and ETFs commission-free!

About LPTX

Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer.

CEO
Doug E. Onsi
Employees
30
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
104.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
520.15K
High Today
$1.66
Low Today
$1.60
Open Price
$1.61
Volume
209.01K
52 Week High
$3.24
52 Week Low
$1.43

LPTX Earnings

-$0.55
-$0.37
-$0.18
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

ARMK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure